
Keywords: T2DM; type 2 diabetes mellitus; MI; myocardial infarction; CAD; coronary artery disease; I R injury; ischemia reperfusion injury; LV; left ventricle; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; PPARs; peroxisome proliferators-activated